World Congress on Thyroid Cancer 3.5
Rome, Italy | 2019
World Congress on Thyroid Cancer 4.0
July 29 – August 1, 2021
WCTC3.5 Steering Committee:
Rocco Bellatone, Co-Chair
Celestino Lombardi, Co-Chair
Gregory W. Randolph, MD
Bryan McIver, MD
Jeremy Freeman, MD
Ian J. Witterick, MD
Ashok R. Shaha, MD
Jatin P. Shah, MD
- Robert Witt's presentations
Professor: Otolaryngology-Head & Neck Surgery, Thomas Jefferson University, Philadelphia
Affiliate Professor: Biological Sciences, University of Delaware, Newark, DE
Principal Investigator NIH RO1 grant
Editor of 2 Thyroid books:
Witt RL,ed. Advances in the Management of Thyroid Cancer, Surgical
Oncology Clinics of North America, 2008.
Witt, RL ed. Thyroid Cancer: Current Diagnosis, Management, and Prognostication, Otolaryngology Clinics of North America 2014
High Volume Thyroid Surgeon
Recent Thyroid Publications with an emphasis on practical end user outcomes:
Diagnosis and Management of Differentiated Thyroid Cancer using Molecular Biology. Laryngoscope 2013;123:1059-1064.
Surgeon Performed Ultrasound Guided FNAC with On-Site Cytopathology improves adequacy and accuracy. Laryngoscope. 2015;125(7) 1633-6.
Outcome of Thyroid Gene Expression Classifier Testing in Clinical Practice. Laryngoscope. 2016;126:524-27.
What is the Best Management of Incidental Papillary Thyroid Microcarcinoma. Laryngoscope. 2016;126(10) 2203-4.
Targeted Next Generation Sequencing with ThyroSeq v2.1 for Indeterminate Thyroid Nodules In Clinical Practice 2016. DE Med J;88(12):366-367.
Molecular Testing for Thyroid Nodules: Review and Current State. Cancer (in press)